MCM
AGN

Maple Capital Management’s Allergan plc AGN Stock Holding History

Maple Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,130
Closed -$215K – 134
2018
Q3 		$215K Sell
1,130
-5,720
-84% -$1.05M 0.05% 126
2018
Q2 		$1.14M Sell
6,850
-14,947
-69% -$2.4M 0.28% 55
2018
Q1 		$3.67M Sell
21,797
-4,058
-16% -$681K 0.91% 37
2017
Q4 		$4.23M Sell
25,855
-90
-0.3% -$16.1K 1.09% 37
2017
Q3 		$5.32M Buy
25,945
+132
+0.5% +$30.7K 1.43% 33
2017
Q2 		$6.28M Buy
25,813
+3,178
+14% +$747K 1.8% 24
2017
Q1 		$5.41M Sell
22,635
-429
-2% -$99.9K 1.6% 29
2016
Q4 		$4.84M Sell
23,064
-245
-1% -$50.8K 1.52% 34
2016
Q3 		$5.37M Buy
23,309
+527
+2% +$129K 1.74% 25
2016
Q2 		$5.26M Buy
22,782
+982
+5% +$226K 1.93% 21
2016
Q1 		$5.84M Sell
21,800
-2,161
-9% -$619K 2.15% 17
2015
Q4 		$7.49M Sell
23,961
-917
-4% -$273K 2.65% 8
2015
Q3 		$6.76M Sell
24,878
-3,417
-12% -$1.05M 2.5% 8
2015
Q2 		$8.59M Sell
28,295
-1,415
-5% -$422K 2.94% 2
2015
Q1 		$8.84M Sell
29,710
-1,043
-3% -$297K 3.08% 2
2014
Q4 		$7.92M Buy
30,753
+752
+3% +$188K 2.86% 4
2014
Q3 		$7.24M Buy
30,001
+621
+2% +$139K 2.74% 4
2014
Q2 		$6.55M Buy
29,380
+13,708
+87% +$2.84M 2.38% 9
2014
Q1 		$3.23M Buy
15,672
+1,141
+8% +$226K 1.25% 35
2013
Q4 		$2.44M Buy
+14,531
New +$2.27M 0.97% 42

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Maple Capital Management's AGN Position: Q4 2018 in Review

Maple Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,130 shares — an estimated $215K sold.

Maple Capital Management first reported a position in AGN in Q4 2013 and held it in 20 quarters. The position peaked at $8.84M in Q1 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Maple Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Maple Capital Management sold 1,130 Allergan plc shares in Q4 2018, an estimated $215K.
  • Maple Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 20 quarters.
  • Maple Capital Management's Allergan plc position peaked at $8.84M in Q1 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Maple Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.